AURE (AURE) Stock Price & Analysis
AURE (AURE) rose 0.52% to USD 1.48 as of September 9, 2026 at 09:42 UTC, according to Nexqual real-time market data.
AURE last closed at USD 1.48; the session ranged USD 1.46–1.53 on volume of 1,565 shares. Market capitalization is —, with a 52-week range of USD 1.25–14.6 (NCM). Source: Nexqual, September 9, 2026 at 09:42 UTC.
Key Statistics (as of September 9, 2026 at 09:42 UTC)
| Price | USD 1.48 |
|---|---|
| Change | ▲ 0.52% (up) |
| Previous Close | USD 1.48 |
| Open | USD 1.48 |
| Day Range | USD 1.46 – 1.53 |
| 52-Week Range | USD 1.25 – 14.6 |
| Volume | 1,565 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (AURE)
Nexqual's technical model rates AURE "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of September 9, 2026 at 09:42 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 40.04 (neutral) |
| vs SMA50 | Below (USD 1.72) |
| MACD | -0.09 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BGLC | BioNexus Gene Lab Corp | USD 1.4 | ▼ 4.76% |
| MGIH | Millennium Group International | USD 1.5 | ▼ 0.66% |
| VCIG | VCI Global Limited | USD 1.8 | ▼ 3.23% |
| SXTP | 60 Degrees Pharmaceuticals, Inc | USD 0.98 | ▲ 5.03% |
| GDC | GD Culture Group Limited | USD 1.45 | ▼ 5.84% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 09:42 UTC. This page is informational and not investment advice.